Literature DB >> 16431202

Rituximab in postpartum-related acquired hemophilia.

Hélène Maillard1, David Launay, Eric Hachulla, Jenny Goudemand, Marc Lambert, Sandrine Morell-Dubois, Viviane Queyrel, Pierre-Yves Hatron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16431202     DOI： 10.1016/j.amjmed.2005.06.068

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.

Authors:  P Machado; J M Raya; T Martín; L Morabito; M L Brito; J M Rodríguez-Martín
Journal:  Int J Hematol       Date:  2008-04-15       Impact factor: 2.490

Review 2.  Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.

Authors:  Carlo Bonfanti; Silvia Crestani; Francesco Frattini; Cinzia Sissa; Massimo Franchini
Journal:  Blood Transfus       Date:  2014-12-17       Impact factor: 3.443

Review 3.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

Review 4.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443

5.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.